会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Cyclohexenone compounds from Antrodia camphorata to treat autoimmune diseases
    • 来自樟芝的环己烯酮化合物治疗自身免疫性疾病
    • US07501454B2
    • 2009-03-10
    • US11882196
    • 2007-07-31
    • Sheng-Yun LiuMao-Tien KuoWu-Che Wen
    • Sheng-Yun LiuMao-Tien KuoWu-Che Wen
    • A61K31/12C07C49/543
    • C07C403/02A61K31/122C07C2601/16
    • The present invention relates to a compound of Antrodia camphorata used to treat autoimmune diseases, in particular to an extract, 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone, isolated from Antrodia camphorata, and its use in alleviating symptoms of autoimmune diseases such as systemic lupus erythematosus (SLE). The cyclohexenone compound according to the present invention helps to decrease proteinuria levels and antinuclear antibody titers in SLE mammals in order to alleviate kidney inflammation and disease, as well as the self-damage caused by antinuclear antibodies. The purpose for prevention and treatment of autoimmune diseases and kidney diseases by the natural, side-effect free substance can then be accomplished.
    • 本发明涉及一种用于治疗自身免疫性疾病的樟芝(Antigdia camphorata)化合物,特别涉及一种提取物,4-羟基-2,3-二甲氧基-6-甲基-5(3,7,11-三甲基 - 十二烷-2) 6,10-三烯基) - 环己-2-烯酮,其用于缓解自身免疫疾病如系统性红斑狼疮(SLE)的症状。 根据本发明的环己烯酮化合物有助于降低SLE哺乳动物中的蛋白尿水平和抗核抗体滴度,以减轻肾脏炎症和疾病,以及由抗核抗体引起的自身损伤。 然后可以实现通过天然的副作用游离物质预防和治疗自身免疫疾病和肾脏疾病的目的。
    • 7. 发明申请
    • CYCLOHEXENONE COMPOUNDS FROM ANTRODIA CAMPHORATA TO TREAT AUTOIMMUNE DISEASES
    • 来自天竺葵的CYCLOHEXENONE化合物治疗自身免疫性疾病
    • US20080312334A1
    • 2008-12-18
    • US11882196
    • 2007-07-31
    • Sheng-Yun LiuMao-Tien KuoWu-Che Wen
    • Sheng-Yun LiuMao-Tien KuoWu-Che Wen
    • A61K31/12A61P37/00C07C49/00
    • C07C403/02A61K31/122C07C2601/16
    • The present invention relates to a compound of Antrodia camphorata used to treat autoimmune diseases, in particular to an extract, 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone, isolated from Antrodia camphorata, and its use in alleviating symptoms of autoimmune diseases such as systemic lupus erythematosus (SLE). The cyclohexenone compound according to the present invention helps to decrease proteinuria levels and antinuclear antibody titers in SLE mammals in order to alleviate kidney inflammation and disease, as well as the self-damage caused by antinuclear antibodies. The purpose for prevention and treatment of autoimmune diseases and kidney diseases by the natural, side-effect free substance can then be accomplished.
    • 本发明涉及一种用于治疗自身免疫性疾病的樟芝(Antigdia camphorata)化合物,特别涉及一种提取物,4-羟基-2,3-二甲氧基-6-甲基-5(3,7,11-三甲基 - 十二烷-2) 6,10-三烯基) - 环己-2-烯酮,其用于缓解自身免疫疾病如系统性红斑狼疮(SLE)的症状。 根据本发明的环己烯酮化合物有助于降低SLE哺乳动物中的蛋白尿水平和抗核抗体滴度,以减轻肾脏炎症和疾病,以及由抗核抗体引起的自身损伤。 然后可以实现通过天然的副作用游离物质预防和治疗自身免疫疾病和肾脏疾病的目的。
    • 8. 发明授权
    • Liver protection compounds of the cyclohexenone type from Antrodia camphorata
    • 来自樟芝的环己烯酮类型的肝保护化合物
    • US07456225B1
    • 2008-11-25
    • US11902599
    • 2007-09-24
    • Sheng-Yun LiuWu-Che WenMao-Tien Kuo
    • Sheng-Yun LiuWu-Che WenMao-Tien Kuo
    • A61K31/12C07C49/543C07C49/557
    • A61K36/07A61K31/12C07C403/02C07C2601/16
    • The present invention relates to a compound of Antrodia camphorata used for liver protection, in particular to an extract, 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone which is isolated from Antrodia camphorata. The cyclohexenone compound according to the invention helps to alleviate liver injury and fibrosis induced by chemicals and reduces the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). By increasing the contents of glutathione peroxidase (GSHPx) and catalase (CAT), cyclohexenone further decreases the liver damage and the oxidative pressure caused by free radicals, enhances the antioxidant ability and achieves the purposed of liver protection.
    • 本发明涉及一种用于肝保护的樟脑类化合物,特别涉及一种提取物,4-羟基-2,3-二甲氧基-6-甲基-5(3,7,11-三甲基 - 十二烷-2,6- ,10-三烯基) - 环己-2-烯酮,其从樟脑中分离。 根据本发明的环己烯酮化合物有助于缓解由化学物质引起的肝脏损伤和纤维化,并降低丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)的水平。 通过增加谷胱甘肽过氧化物酶(GSHPx)和过氧化氢酶(CAT)的含量,环己烯酮进一步降低了肝脏损伤和自由基引起的氧化压力,提高了抗氧化能力,达到了肝脏保护的目的。